Artificial Intelligence (AI) in pathology refers to the use of AI techniques, such as machine learning and deep learning algorithms, to assist pathologists in the analysis, interpretation, and diagnosis of medical images and specimens. Pathology is the medical specialty that focuses on the study of disease through the examination of tissue samples, cells, and bodily fluids.

The global Artificial Intelligence in Pathology market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Artificial Intelligence in Pathology Industry Forecast” looks at past sales and reviews total world Artificial Intelligence in Pathology sales in 2022, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence in Pathology sales for 2023 through 2029.

With Artificial Intelligence in Pathology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence in Pathology industry.

This Insight Report provides a comprehensive analysis of the global Artificial Intelligence in Pathology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Artificial Intelligence in Pathology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence in Pathology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence in Pathology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence in Pathology.

United States market for Artificial Intelligence in Pathology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Artificial Intelligence in Pathology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Artificial Intelligence in Pathology is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Artificial Intelligence in Pathology players cover:

• PathAI
• Proscia
• Aiforia
• Deep Bio
• Hologic

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence in Pathology market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Diagnosis Support
• Predictive Modeling
• Pattern Recognition
• Image Analysis and Detection
• Other

Segmentation by Application:

• Hospital
• Diagnostic Centers
• Laboratories & Research Institutes

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• PathAI
• Proscia
• Aiforia
• Deep Bio
• Hologic
• Dipath
• iDeepwise
• LBP
• F.Q pathtech
• CellaVision
• AIRA Matrix
• Syntropy
• Indica Labs
• DoMore Diagnostics
• Mindpeak
• Evidium